MA33804B1 - Composition pharmaceutique pour le traitement des brûlures cutanées - Google Patents
Composition pharmaceutique pour le traitement des brûlures cutanéesInfo
- Publication number
- MA33804B1 MA33804B1 MA34941A MA34941A MA33804B1 MA 33804 B1 MA33804 B1 MA 33804B1 MA 34941 A MA34941 A MA 34941A MA 34941 A MA34941 A MA 34941A MA 33804 B1 MA33804 B1 MA 33804B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- skin burns
- burns
- pharmaceutical formula
- skin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 231100000075 skin burn Toxicity 0.000 title abstract 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 abstract 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE2009/0780A BE1019105A4 (nl) | 2009-12-11 | 2009-12-11 | Emulsion pour annihiler les effets de brulure thermique sur la peau. |
| PCT/EP2010/069412 WO2011070168A1 (fr) | 2009-12-11 | 2010-12-10 | Composition pharmaceutique pour le traitement des brûlures cutanées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33804B1 true MA33804B1 (fr) | 2012-12-03 |
Family
ID=42270216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34941A MA33804B1 (fr) | 2009-12-11 | 2012-06-05 | Composition pharmaceutique pour le traitement des brûlures cutanées |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8597696B2 (enExample) |
| EP (1) | EP2509584B1 (enExample) |
| JP (1) | JP5781532B2 (enExample) |
| KR (1) | KR20120123660A (enExample) |
| CN (1) | CN102781426B (enExample) |
| AU (1) | AU2010329838B2 (enExample) |
| BE (1) | BE1019105A4 (enExample) |
| BR (1) | BR112012013825A2 (enExample) |
| CA (1) | CA2784928C (enExample) |
| DK (1) | DK2509584T3 (enExample) |
| ES (1) | ES2464043T3 (enExample) |
| IN (1) | IN2012DN06060A (enExample) |
| MA (1) | MA33804B1 (enExample) |
| MX (1) | MX2012006695A (enExample) |
| MY (1) | MY162654A (enExample) |
| NZ (1) | NZ600187A (enExample) |
| PL (1) | PL2509584T3 (enExample) |
| PT (1) | PT2509584E (enExample) |
| RU (1) | RU2600815C2 (enExample) |
| WO (1) | WO2011070168A1 (enExample) |
| ZA (1) | ZA201204341B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169814A (zh) * | 2013-04-07 | 2013-06-26 | 重庆涪江生物科技有限公司 | 用于辅助治疗烧烫伤的复方精油 |
| US9226890B1 (en) | 2013-12-10 | 2016-01-05 | Englewood Lab, Llc | Polysilicone base for scar treatment |
| WO2016071804A1 (fr) | 2014-11-04 | 2016-05-12 | 45Sec Llc | Emulsion pharmaceutique visant a l'equilibre therapeutique des pressions internes de la peau humaine et animale |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099866A (en) * | 1986-01-31 | 2000-08-08 | Slimak; K. M. | Compositions for topical application and other products from fresh beeswaxes |
| BE1002340A6 (nl) * | 1988-07-28 | 1990-12-27 | Den Daele Marc Van | Geneesmiddel voor de behandeling van brandwonden. |
| BE1004300A6 (nl) * | 1989-06-16 | 1992-10-27 | Sollie Philippe | Geneesmiddel voor het behandelen van een droge jeukende huid. |
| DE19504398A1 (de) * | 1995-02-10 | 1996-08-14 | Beiersdorf Ag | Tocopherylglycoside, ihre Herstellung sowie ihre Verwendung als Tenside, als Antioxidantien sowie als der Zellalterung vorbeugender Wirkstoff in kosmetischen oder pharmazeutischen Zubereitungen |
| CN1062736C (zh) * | 1995-11-23 | 2001-03-07 | 苏克俭 | 烧伤外用乳浊液 |
| US5958420A (en) * | 1997-03-13 | 1999-09-28 | Nortrade Medical, Inc. | Treatment of burns, cuts, and abrasions of the skin |
| US6027716A (en) * | 1997-04-02 | 2000-02-22 | Farmo-Nat Ltd. | Synergistic herbal extracts |
| IL127943A (en) * | 1999-01-07 | 2010-12-30 | Shlomo Magdassi | Pharmaceutical and cosmetic compositions for the treatment of skin disorders |
| US7285570B2 (en) * | 2003-04-17 | 2007-10-23 | The Procter & Gamble Company | Compositions and methods for regulating mammalian keratinous tissue |
| CN1481861A (zh) * | 2003-07-01 | 2004-03-17 | 张德明 | 烧、烫伤外用治疗药剂 |
| KR101045658B1 (ko) * | 2003-11-17 | 2011-07-01 | 쎄데르마 | 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물 |
| US20080031905A1 (en) * | 2006-08-02 | 2008-02-07 | Cram John O | Method for treatment of burns |
| US20090258085A1 (en) * | 2008-03-17 | 2009-10-15 | Ahava- Dead Sea Laboratories Ltd. | Emulsions and methods of their production |
-
2009
- 2009-12-11 BE BE2009/0780A patent/BE1019105A4/fr not_active IP Right Cessation
-
2010
- 2010-12-10 PL PL10790436T patent/PL2509584T3/pl unknown
- 2010-12-10 BR BR112012013825A patent/BR112012013825A2/pt not_active Application Discontinuation
- 2010-12-10 CN CN201080056120.3A patent/CN102781426B/zh not_active Expired - Fee Related
- 2010-12-10 DK DK10790436.9T patent/DK2509584T3/da active
- 2010-12-10 US US13/514,625 patent/US8597696B2/en active Active
- 2010-12-10 PT PT107904369T patent/PT2509584E/pt unknown
- 2010-12-10 KR KR1020127017824A patent/KR20120123660A/ko not_active Abandoned
- 2010-12-10 NZ NZ600187A patent/NZ600187A/xx not_active IP Right Cessation
- 2010-12-10 AU AU2010329838A patent/AU2010329838B2/en not_active Ceased
- 2010-12-10 MY MYPI2012002576A patent/MY162654A/en unknown
- 2010-12-10 JP JP2012542567A patent/JP5781532B2/ja not_active Expired - Fee Related
- 2010-12-10 RU RU2012125193/15A patent/RU2600815C2/ru not_active IP Right Cessation
- 2010-12-10 CA CA2784928A patent/CA2784928C/en not_active Expired - Fee Related
- 2010-12-10 MX MX2012006695A patent/MX2012006695A/es active IP Right Grant
- 2010-12-10 EP EP10790436.9A patent/EP2509584B1/fr not_active Not-in-force
- 2010-12-10 WO PCT/EP2010/069412 patent/WO2011070168A1/fr not_active Ceased
- 2010-12-10 ES ES10790436.9T patent/ES2464043T3/es active Active
-
2012
- 2012-06-05 MA MA34941A patent/MA33804B1/fr unknown
- 2012-06-13 ZA ZA2012/04341A patent/ZA201204341B/en unknown
- 2012-07-07 IN IN6060DEN2012 patent/IN2012DN06060A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201204341B (en) | 2013-08-28 |
| EP2509584A1 (fr) | 2012-10-17 |
| EP2509584B1 (fr) | 2014-02-19 |
| CN102781426B (zh) | 2015-01-07 |
| WO2011070168A1 (fr) | 2011-06-16 |
| MX2012006695A (es) | 2012-10-15 |
| US20120237627A1 (en) | 2012-09-20 |
| AU2010329838A1 (en) | 2012-06-28 |
| KR20120123660A (ko) | 2012-11-09 |
| PL2509584T3 (pl) | 2014-08-29 |
| US8597696B2 (en) | 2013-12-03 |
| ES2464043T3 (es) | 2014-05-30 |
| RU2012125193A (ru) | 2014-01-20 |
| RU2600815C2 (ru) | 2016-10-27 |
| CA2784928A1 (en) | 2011-06-16 |
| JP2013513579A (ja) | 2013-04-22 |
| JP5781532B2 (ja) | 2015-09-24 |
| AU2010329838B2 (en) | 2015-10-29 |
| CA2784928C (en) | 2018-06-05 |
| NZ600187A (en) | 2013-04-26 |
| CN102781426A (zh) | 2012-11-14 |
| IN2012DN06060A (enExample) | 2015-09-18 |
| BE1019105A4 (nl) | 2012-03-06 |
| BR112012013825A2 (pt) | 2019-09-17 |
| PT2509584E (pt) | 2014-05-12 |
| DK2509584T3 (da) | 2014-05-12 |
| MY162654A (en) | 2017-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| NZ591810A (en) | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid | |
| SG196775A1 (en) | Chromenone analogs as sirtuin modulators | |
| MA28437B1 (fr) | Composes et leurs procedes d'utilisation | |
| MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
| MX2010003774A (es) | Formulaciones oftalmicas acuosas. | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| MA29169B1 (fr) | Formulations intraveineuses d'inhibiteurs de la pde-5 | |
| MA32686B1 (fr) | Composés, compositions et procédés pour le traitement de maladies de la b-amyloïde et de synucléinopathies | |
| EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
| TW200503668A (en) | Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors | |
| FR2952372B1 (fr) | Nouveaux derives de mannopyranoside ayant une activite anticancereuse | |
| EA200901237A1 (ru) | Применение димирацетама при лечении хронической боли | |
| AU2001266289A1 (en) | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury | |
| MA33804B1 (fr) | Composition pharmaceutique pour le traitement des brûlures cutanées | |
| BR0315462A (pt) | Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação | |
| EP2269996A4 (en) | A BENZO [A] PHENOXANTHINE COMPOUND CONTAINING AN ACTIVE MEDICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY PROTOZON | |
| BR0313589A (pt) | Uso de extrato de germe de trigo fermentado como agente antiinflamatório | |
| WO2006108679A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer | |
| MX366496B (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. | |
| MY182553A (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
| EP2351567A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF DIABETES OR ADIPOSITAS CONNECTED TO THE INHIBITION OF DIPEPTIDYLPEPTIDASE IV ACTIVITY AND OTHER ANTI-DIABETICS AND ANTIADIPOSITA AS ACTIVE AGENTS | |
| WO2007017146A3 (en) | Use of collismycin and derivatives thereof as oxidative stress inhibitors |